YAP1 and cancer: To extrapolate those findings to a human model, they analyzed superficial, nodular, and infiltrative types of human BCC using immunostaining and provided evidence that, regardless of any cancer-initiating event (oncogene activation, tumor suppressor mutation) or BCC histological subtype, nuclear YAP expression takes place [29].